Q1 2026 Holdings
Filed 2026-05-14 | 450 holdings | $362.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immatics N.v(IMTX) | SHS | N44445109 | $267.2K | 27,159 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $267.4K | 76,169 | 0.1% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $268.0K | 10,702 | 0.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $272.6K | 9,131 | 0.1% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $273.5K | 12,664 | 0.1% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $274.1K | 8,418 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $275.0K | 16,718 | 0.1% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $279.6K | 52,846 | 0.1% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $281.8K | 9,007 | 0.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $283.6K | 4,303 | 0.1% |
| Omeros Corp(OMER) | COM | 682143102 | $283.7K | 26,865 | 0.1% |
| Main STR Cap Corp(MAIN) | COM | 56035L104 | $284.9K | 5,380 | 0.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $285.9K | 5,816 | 0.1% |
| Precigen Inc(PGEN) | COM | 74017N105 | $286.0K | 73,899 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $288.0K | 80,438 | 0.1% |
| Monroe Cap Corp(MRCC) | COM | 610335101 | $288.1K | 62,628 | 0.1% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $289.3K | 20,815 | 0.1% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $291.2K | 15,166 | 0.1% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $293.5K | 14,755 | 0.1% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $294.1K | 20,920 | 0.1% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $294.2K | 15,519 | 0.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $295.5K | 2,589 | 0.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $297.8K | 3,538 | 0.1% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $301.4K | 2,860 | 0.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $304.0K | 54,866 | 0.1% |
| Immunome Inc(IMNM) | COM | 45257U108 | $304.7K | 13,932 | 0.1% |
| Cytomx Therapeutics Inc.(CTMX) | COM | 23284F105 | $305.9K | 65,080 | 0.1% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $307.6K | 1,929 | 0.1% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $308.3K | 8,169 | 0.1% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $314.4K | 9,911 | 0.1% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $318.6K | 10,479 | 0.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $318.8K | 11,286 | 0.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $319.4K | 6,058 | 0.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $325.1K | 22,875 | 0.1% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $326.4K | 1,013 | 0.1% |
| OFS Cap Corp(OFS) | COM | 67103B100 | $329.0K | 92,665 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $335.9K | 3,454 | 0.1% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $336.5K | 6,067 | 0.1% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $337.9K | 33,957 | 0.1% |
| Triplepoint Venture Growth B(TPVG) | COM | 89677Y100 | $341.9K | 68,513 | 0.1% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $343.6K | 18,436 | 0.1% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $344.7K | 2,765 | 0.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $356.0K | 6,126 | 0.1% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $358.6K | 4,984 | 0.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $359.8K | 6,188 | 0.1% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $363.3K | 28,562 | 0.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $363.6K | 11,544 | 0.1% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $365.2K | 40,759 | 0.1% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $368.3K | 29,069 | 0.1% |
| Oxford Square Cap Corp(OXSQ) | COM | 69181V107 | $377.9K | 213,488 | 0.1% |